Table 1.
Clinicopathological characteristics of patients.
| Variables | Frequency (n = 19) |
|---|---|
| Age | |
| >40 | 15 (78.9%) |
| ≤40 | 4 (21.1%) |
| Gender | |
| Male | 16 (84.2%) |
| Female | 3 (15.8%) |
| Habits | |
| Chewed tobacco | 12 (63.1%) |
| Smoked tobacco | 6 (31.6%) |
| No habit | 1 (5.3%) |
| Tumour site | |
| Buccal mucosa | 8 (42.1%) |
| Mandible | 3 (15.8%) |
| Tongue | 3 (15.8%) |
| Retromolar trigone | 3 (15.8%) |
| Maxilla | 2 (10.5%) |
| Tumour size | |
| pT2 | 4 (21.1%) |
| pT3 | 7 (36.8%) |
| pT4a | 8 (42.1%) |
| Tumour grade | |
| Well differentiated | 3 (15.8%) |
| Moderately differentiated | 12 (63.2%) |
| Poorly differentiated | 4 (21.1%) |
| Nodal Status | |
| Yes | 12 (63.2%) |
| No | 7 (36.8%) |
| pTNM∗staging | |
| pT2, pN0, pMx | 2 (10.5%) |
| pT2, pN1, pMx | 2 (10.5%) |
| pT3, pN0, pMx | 1 (5.3%) |
| pT3, pN1, pMx | 1 (5.3%) |
| pT3, pN2a, pMx | 1 (5.3%) |
| pT3, pN2b, pMx | 4 (21.1%) |
| pT4a, pN0, pMx | 4 (21.1%) |
| pT4a, pN1, pMx | 2 (10.5%) |
| pT4a, pN2b, pMx | 2 (10.5%) |
pTNM = pathological tumour node metastasis staging College of American Pathologists (CAP) protocol for lip & oral cavity cancer).